Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

3 days ago 3

Laiba Immad

Thu, June 25, 2026 astatine 7:42 AM CDT 2 min read

We precocious compiled a database of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Innoviva, Inc. (NASDAQ:INVA) is 1 of the most promising stocks on our list.

TheFly reported connected June 18 that INVA announced the motorboat of Nortiva Bio, a clinical-stage biopharmaceutical institution focused connected processing long-acting oral therapies done its proprietary LYNX cause transportation platform. The exertion is designed to person accepted regular oral medicines into extended-release treatments with imaginable dosing intervals of up to 1 month.

Nortiva aims to amended attraction effectiveness, safety, medicine adherence, and diligent experiences crossed aggregate therapeutic areas. The institution operates arsenic a wholly owned subsidiary of INVA pursuing the acquisition of the LYNX level from Lyndra Therapeutics successful 2025.

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

Separately, connected June 16, Innoviva, Inc. (NASDAQ:INVA) Specialty Therapeutics, a subsidiary of INVA, announced an exclusive organisation and licensing statement with Dr. Reddy's Laboratories for XACDURO successful selected planetary markets. Under the agreement, Dr. Reddy's volition oversee development, regulatory processes, and commercialization efforts crossed South and Central America, the Caribbean, Russia, and the Commonwealth of Independent States countries.

Innoviva Specialty Therapeutics will maintain rights to XACDURO successful markets extracurricular the licensed regions. The institution is besides eligible to person upfront payments, milestone-based payments tied to regulatory and commercialized progress, and royalties from income generated wrong the covered territories.

Innoviva, Inc. (NASDAQ:INVA) is simply a biopharmaceutical institution focused connected captious attraction and infectious illness treatments, supported by unchangeable gross from its respiratory royalty portfolio and investments successful innovative therapies.

While we admit the imaginable of INVA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article